Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted
If you have questions or concerns about your progressor still feel hungry on semaglutide discuss them with a licensed healthcare provider who can evaluate whats appropriate for your specific circumstances
Hepatology 2002
Metformin inhibits nuclear factor-KB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro
US$ 26.11
US$ 23.37
US$ 29.38
